// STATE LEGISLATION TRACKER

Kentucky SB 174 — AN ACT relating to the supervision of pharmacy technicians.

⚖️ NEUTRAL for peptide users 👤 LOW user impact 📜 Status: In committee

State: Kentucky
Bill: SB 174
Filed: 2026-02-10
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Kentucky SB174 would stop the Kentucky Board of Pharmacy from requiring immediate supervision when pharmacy technicians stock, retrieve, or return products in a nonretail pharmacy setting. It does not appear to address compounded peptides, off-label prescribing, telehealth, NP or naturopathic scope, FDA 503A/503B rules, controlled substances, or prescription monitoring.

Key Points

No direct change to peptide prescribing or patient access is shown
Could modestly ease workflow for nonretail pharmacies handling inventory
No specific compounding rule change is identified
No telehealth or clinician scope expansion is identified

What to Watch For

✓

Opportunity Nonretail pharmacies may get more flexibility in technician inventory tasks if the bill advances.

Note Watch for amendments that add compounding, sterile products, or prescription fulfillment language.

Note Current text appears operational, not a peptide access or prescribing bill.

Where the Bill Stands

The bill was introduced in the Senate on February 10, 2026 and sent to the Senate Committee on Committees.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws